James Anderson is the Chair of the INTREPID Alliance and the Executive Director of Global Health at the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), a leading global organization representing pharmaceutical companies. In his role at IFPMA, James spearheads efforts to address critical global health challenges, including antimicrobial resistance, pandemic preparedness, and non-communicable diseases.

New England Biolabs (NEB) has introduced the NEBNext Low-bias Small [...]

AltPep Corporation has presented new preclinical findings at the Alzheimer’s [...]

Nanoscope Therapeutics has initiated a rolling submission for its Biologics [...]

New study proposes AI-driven framework to refine gene target discovery [...]

The case for smarter collaboration in CGT manufacturing  As the [...]

Regulators back AI and organ-on-a-chip technologies to modernize safety evaluation [...]

Cleanroom microbiology expert Cherwell, an Analytichem company, has launched a [...]

Cleanroom microbiology expert Cherwell, an Analytichem company, has launched a [...]

Chrysalis, a GMP-compliant space and service provider, has formally launched [...]